Health InnoFacilitator aims to create a community leveraging capabilities and promoting innovation procurement within healthcare. Provide support, tailor-made training and coaching services for buyers and suppliers, develop and foster a community supported by online collaborative tools. Increase the awareness, skills and knowledge about innovation procurement among the buyers and the solution providers/ actors of innovation, build capabilities and therefore fostering the innovation procurement capabilities within the community, providing trainings, mentoring and coaching and supporting the community, which will in return, improve SMEs and startups access to innovation procurement, leverage capability among the buyers to develop innovation procurement, foster public and private partnership to encourage the co-design of innovation procurement (matching the buyers’ needs and helping the buyers to identify existing innovative solutions and to identify their needs for research and development).

Additive Manufacturing (AM) is proving to be a disruptive enabling technology with a huge potential to be applied in the Health Sector (HS) . If there was still any doubt, the current situation with COVID19 has shown the potential, flexibility and agility of this technology to answer critical situations (1).Then why has not been globally integrated in hospitals? There are recognised barriers to the integration of AM in HS, one of them being the lack of knowledge and skills on the use of technology and the related organizational models (2).ALADDIN aims to contribute to this integration by developing a specific training programme on AM in Hospitals (as health cornerstones they will have a multiplying effect in the whole HS) for two key players identified in the European value chain on AM medical devices (3): - health professionals working in hospitals (doctors, surgeons, biotechnologists, ...) - engineering students for their future incorporation into the health sector.It will have the next specific objectives:- Develop an innovative training on AM in Hospitals. (First version m12 final version m24).- Assess the training programme, the materials and the contents developed through pilot training courses.- Disseminate project results to the main stakeholders at European Level. It is estimated to reach 5000 stakeholders (see Follow-up section for more information).- Exploit project results after the end of the project.The execution of the Project will be structured according to:1.Development of Training Methodology and the Teaching guide.2.Development of Training Contents.3.Development of the E-learning Platform.4.Pilot Training activities.Consortium is composed by 6 members with complementary capacities and in charge of different project activities.- AIMPLAS, the Technological Institute of Plastics with more than 500 associated companies. They have participated in more than 100 EU projects (FP5, FP6, FP7, LIFE+, EcoInnova. & H2020). AIMPLAS will coordinate the project and will be in charge of the Development of the Training Contents.- Jobs@skills (Belgium) is an incubator of high level innovative lifelong-learning training programs located in Belgium. They gather local universities, higher education schools and local public training centers around strategic and innovative training topics. Very much active in “New ways of learning”, with lot of expertise, methodologies and top level equipments to produce Digital learning and Hybrid learning products such as MOOCS, SPOCS, Webinars, Virtual classrooms, Gamification. They will be in charge of the Development of the Training Methodology.- The Advanced Manufacturing Research Centre is part of the AMRC Group, a cluster of world-class centres for industry-focused research and development of technologies used in high-value manufacturing sectors. It has a global reputation and has become a model for collaborative research involving universities, academics and industry, worldwide. AMRC will be in charge of the Development of the Eplatform.- ITEMAS aims to promote innovation in medical technology as an essential tool in making the Spanish National Health System more sustainable. The core of the ITEMAS comprises the innovation units of 30 large hospitals, in addition to the Ministry of Health, Social Services and Equality and the National Centre for Cardiovascular Research (CNIC). They will be in charge of the Validation Actions as well as of the quality assurance of the project.- NUI Galway representing the Translational Medical Device Lab & Health Innovation Hub Ireland (HIHI). Partnership of clinical and academic centres. HIHI works directly with 23 public hospitals in Ireland.. HIHI will be in charge of the Exploitation and Sustainability activities of the project.- The European Hospital and Healthcare Federation (HOPE) is a European non-profit association that includes national hospital associations or representatives from national hospital owners’ organisations of the 27 Member States of the European Union. HOPE members cover almost 80% of hospital activity in the EU. They will be in charge of Communication Activities.The main results of the project will be the Training on AM for health professionals working in hospitals and engineering students for their future incorporation into the health sector, which will have an impact at long term by allowing HS to get the most of AM technology so it will on one side contribute to increase the quality of the Healthcare system and on the other increase the competitivity of the AM Industry.(1)https://www.euractiv.com/section/digital/news/eu-industry-touts-3d-printing-as-immediate-solution-to-covid-19-shortages/ (2)The future of Health Care. Potential impacts and models of 3D printing in the Health Care sector. Deloitte 2018(3)https://ec.europa.eu/growth/tools-databases/kets-tools/sites/default/files/documents/analytical_report_nr6_3d_printed_medical_devices_fina

Medication errors occur daily and form a major burden to society. Medication errors often lead to adverse drug reactions, lengthened hospital stays, increased healthcare costs, and in the most severe cases, increased mortality. Medication errors pose a significant risk to the European population. It is estimated that 4,7 million Europeans are harmed by a medication error every year, which amounts to preventable healthcare costs in excess of €11 billion a year. Strikingly, around 50% of medication errors can be stopped at the patient’s bedside. MedEye is an innovative medication verification suite that scans, detects and verifies medication at the bedside. MedEye stops medication errors from taking place by verifying medication before it is administered to patients. MedEye has already been tested and validated in three Dutch hospitals with excellent results. In this project, activities will be performed to push MedEye onto the European market and facilitate its deployment on a large scale. MedEye will be integrated with IT systems that serve a major part of European medical centers. Developments will also be performed to enable the sale, deployment and support of MedEye through distributors. Two launching pilots will be performed to establish transnational proof of performance and cost-effectiveness, which will be instrumental in penetrating the European markets. Given the diversity of the European healthcare landscape, a thorough market research will be performed to gear the commercialization strategy towards individual countries. Together, the activities in this project will provide access to the main EU market and facilitate a wide deployment of MedEye throughout Europe.

There are many efforts at European level to improve our ability to monitor health and to prevent, detect, treat and manage disease so that active and healthy ageing can be promoted. In this project, breakthrough research and radical innovation on new services for integrated care is achieved by means of an efficient and cost-effective service-oriented ICT-based collaborative platform which exploits latest advances in sensorization, processing, communications and personalized HMI. ICT4Life will develop a modular Health Service Platform that will allow the provision, easily and in an adaptive way, of 6 ICT4Life Cluster Services for integrated care according to different end-user needs. Addressing the priorities of the European Innovation Partnership on Active and Healthy Ageing, a multidisciplinary approach which integrates expertise and knowledge of medical doctors, nurses, social workers, psychologists, physiotherapists, social scientists, patients as well as programmers and interaction designers is proposed. It relies, from a general perspective, on: New training models for the care workforce; advanced multisensory-based analytics and integration with biomedical devices to have patient activity and health status information; Feedback-based decision-making engine to integrate patient and care provider data; Improve natural interaction mechanisms with patients with interfaces through television with Android TV possibilities, smartphones and desktop applications; Knowledge creation about co-morbidities. Focusing on real medical problems, people with Dementia, Alzheimer or Parkinson disease, constitute the main group of users ICT4Life will focus the analysis on. ICT4Life validation will be done in real use case scenarios in 3 European countries of all this pathologies in order to validate ICT4Life services, measure effects of treatment and project developments and to evaluate knowledge acquired about co-morbidities of these diseases.